Getting up at night to pee is common in men — and the cause decides the fix
Nocturia is usually blamed on the prostate, but the commonest driver is the kidneys making too much urine overnight. In one trial, low-dose desmopressin trimmed nightly voids and bought about 40 extra minutes of sleep.
Waking once or more each night with a full bladder — doctors call it nocturia — is one of the most common reasons men lose sleep as they age, and one of the most misunderstood [s2]. The instinct is to blame the prostate. Sometimes that is right, but the single most common driver is unglamorous: the kidneys simply make too much urine overnight [s2]. Because the cause varies, the fix varies, and the most useful first step is not a drug but a bladder diary [s2].
It is not always the prostate
Nocturia has a handful of distinct mechanisms, and men often have more than one [s2]. Nocturnal polyuria — producing a disproportionate share of the day's urine while asleep — is the commonest, and it has nothing directly to do with the prostate. Reduced bladder storage, from benign prostatic hyperplasia (an enlarged prostate) or an overactive bladder, means smaller volumes trigger the urge. Global polyuria points elsewhere: poorly controlled diabetes, or simply drinking a lot, especially alcohol or caffeine in the evening. And sleep disorders, obstructive sleep apnoea in particular, can wake a man who then notices a full bladder rather than the breathing pause that actually roused him [s2].
That last point matters because it changes what should be treated. The International Continence Society's consensus stresses working through these causes with a fluid-and-void diary before reaching for medication, and screening for apnoea, heart or kidney problems, and diabetes when the picture warrants it [s2]. A diary that records how much a man drinks and passes, and when, often reveals the pattern at a glance: a night-heavy output points to the kidneys, while small, frequent daytime and night-time volumes point to the bladder [s2].
When the prostate is the problem
If an enlarged prostate is restricting flow and shrinking effective bladder capacity, treating the gland can help the night-time symptom. US guidelines put alpha-blockers such as tamsulosin and 5-alpha-reductase inhibitors such as finasteride at the centre of medical management for bothersome lower urinary tract symptoms attributed to benign prostatic hyperplasia [s3]. But nocturia is often the symptom that responds least well to prostate drugs, precisely because it is frequently driven by the kidneys rather than the bladder outlet [s2].
The drug for night-time urine overproduction
When nocturnal polyuria is the culprit, the targeted treatment is desmopressin, a synthetic version of the hormone that tells the kidneys to concentrate urine overnight. In a three-month randomised trial of 385 men, low-dose orally disintegrating desmopressin at 50 and 75 µg cut the mean number of nightly voids by 0.37 and 0.41 respectively compared with placebo, and roughly doubled the odds of achieving at least a one-third reduction in voids (odds ratios 1.98 and 2.04) [s1]. It bought men about 40 extra minutes before the first trip to the toilet, the benefit appeared within a week, and sleep quality improved [s1].
Those are real but modest gains — well under one avoided void per night on average — and they carry a specific risk. Desmopressin can push blood sodium too low (hyponatraemia). In the trial, two men on the 50 µg dose fell below 130 mmol/L, versus nine on 75 µg, which is why 50 µg is treated as the minimum effective dose and the safer starting point [s1]. The consensus guidance restricts desmopressin to men without excessive thirst, heart or kidney failure, significant leg swelling or sleep apnoea, and calls for a sodium check within the first week and again at a month [s2].
What this means in practice
The honest summary is that "getting up at night" is a symptom, not a diagnosis, and chasing it with the wrong remedy — a prostate drug for a kidney problem, or the reverse — is why so many men stay tired. Simple measures come first: shifting fluids earlier in the day, easing off evening alcohol and caffeine, and reviewing the timing of any diuretic ("water") tablets with a doctor [s2].
Some patterns warrant prompt medical attention rather than self-management: blood in the urine, pain on passing it, or new, heavy night-time urination alongside unexplained thirst and weight loss, which can signal diabetes [s2]. This article describes the evidence, not a treatment plan for any individual — but it should reframe the question a man takes to the clinic, from "how do I shrink my prostate" to "why, exactly, am I making urine at night."
Sources
- [s1] Efficacy and Safety of Low Dose Desmopressin Orally Disintegrating Tablet in Men with Nocturia — Journal of Urology, 2013
- [s2] International Continence Society consensus on the diagnosis and treatment of nocturia — Neurourology and Urodynamics, 2019
- [s3] Management of LUTS Attributed to BPH: AUA Guideline Part I — Journal of Urology, 2021
Sources
- Efficacy and Safety of Low Dose Desmopressin Orally Disintegrating Tablet in Men with Nocturia: Results of a Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group Study — Journal of Urology , September 1, 2013
- International Continence Society consensus on the diagnosis and treatment of nocturia — Neurourology and Urodynamics , February 19, 2019
- Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline Part I — Initial Work-up and Medical Management — Journal of Urology (American Urological Association) , August 13, 2021
More on
For an enlarged prostate, two drug classes work — and combining them works better
Alpha-blockers ease symptoms within weeks; 5-alpha-reductase inhibitors shrink the gland over months. In a 3,047-man trial, combining them cut progression risk by 66%. Newer office procedures spare sexual function.
Does saw palmetto help the prostate or hair loss? For the prostate, the answer is no
The bestselling herbal for an enlarged prostate flopped in the trials: even at triple the usual dose it beat placebo by nothing. The hair-loss claim rests on a handful of small, weak studies rather than proof.
Testosterone therapy helps symptomatic men — but most low readings don't need it
The TRAVERSE trial cleared its cardiovascular safety in 5,246 high-risk men; the Testosterone Trials found a real but moderate sexual-function benefit. Guidelines reserve it for genuine, twice-confirmed deficiency.
For erectile dysfunction, the pills work — and they're the evidence-backed first step
A network meta-analysis of 118 trials and 31,195 men found every oral PDE5 inhibitor beat placebo, with tadalafil ranked most effective. Guidelines make the tablets, after a health check, the first-line choice.